A two-fold ambition for Evolucare: international expansion and artificial intelligence

A two-fold ambition for Evolucare: international expansion and artificial intelligence

A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial Intelligence, for instance with its new product OphtAI for the detection of diabetic retinopathy, and international expansion to reach its ambitions.